Laminarin, a dectin-1 antagonist, reduced the number of IBA1-positive cells and the expression of tumor necrosis factor and induced nitric oxide synthase on the third day after ischemic stroke, which reduced the volume of cerebral infarction and improved nerve function [14]. The gene discussed is AIF1; the disease is ischemic stroke.